Literature DB >> 26314081

Oxidative stress as a therapeutic perspective for ATM-deficient chronic lymphocytic leukemia patients.

Veronika Navrkalova1, Leona Raskova Kafkova2, Vladimir Divoky3, Sarka Pospisilova4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26314081      PMCID： PMC5004413          DOI： 10.3324/haematol.2015.130260

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  20 in total

Review 1.  The DNA damage response: ten years after.

Authors:  J Wade Harper; Stephen J Elledge
Journal:  Mol Cell       Date:  2007-12-14       Impact factor: 17.970

Review 2.  Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?

Authors:  Simran S Sabharwal; Paul T Schumacker
Journal:  Nat Rev Cancer       Date:  2014-11       Impact factor: 60.716

3.  Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib.

Authors:  John C Byrd; Richard R Furman; Steven E Coutre; Jan A Burger; Kristie A Blum; Morton Coleman; William G Wierda; Jeffrey A Jones; Weiqiang Zhao; Nyla A Heerema; Amy J Johnson; Yun Shaw; Elizabeth Bilotti; Cathy Zhou; Danelle F James; Susan O'Brien
Journal:  Blood       Date:  2015-02-19       Impact factor: 22.113

4.  ATM activation by oxidative stress.

Authors:  Zhi Guo; Sergei Kozlov; Martin F Lavin; Maria D Person; Tanya T Paull
Journal:  Science       Date:  2010-10-22       Impact factor: 47.728

5.  Targeting the Ataxia Telangiectasia Mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants.

Authors:  Angelo Agathanggelou; Victoria J Weston; Tracey Perry; Nicholas J Davies; Anna Skowronska; Daniel T Payne; John S Fossey; Ceri E Oldreive; Wenbin Wei; Guy Pratt; Helen Parry; David Oscier; Steve J Coles; Paul S Hole; Richard L Darley; Michael McMahon; John D Hayes; Paul Moss; Grant S Stewart; A Malcolm R Taylor; Tatjana Stankovic
Journal:  Haematologica       Date:  2015-04-03       Impact factor: 9.941

Review 6.  Modulation of oxidative stress as an anticancer strategy.

Authors:  Chiara Gorrini; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Drug Discov       Date:  2013-12       Impact factor: 84.694

7.  ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin.

Authors:  Veronika Navrkalova; Ludmila Sebejova; Jana Zemanova; Jana Kminkova; Blanka Kubesova; Jitka Malcikova; Marek Mraz; Jana Smardova; Sarka Pavlova; Michael Doubek; Yvona Brychtova; David Potesil; Veronika Nemethova; Jiri Mayer; Sarka Pospisilova; Martin Trbusek
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

8.  Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling.

Authors:  Gaël Roué; Mónica López-Guerra; Pierre Milpied; Patricia Pérez-Galán; Neus Villamor; Emili Montserrat; Elias Campo; Dolors Colomer
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

Review 9.  Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions.

Authors:  Mark Ambrose; Richard A Gatti
Journal:  Blood       Date:  2013-02-25       Impact factor: 22.113

Review 10.  Exploiting synthetic lethal interactions for targeted cancer therapy.

Authors:  H Christian Reinhardt; Hai Jiang; Michael T Hemann; Michael B Yaffe
Journal:  Cell Cycle       Date:  2009-10-01       Impact factor: 4.534
View more
  1 in total

1.  Emodin Sensitizes Cervical Cancer Cells to Vinblastine by Inducing Apoptosis and Mitotic Death.

Authors:  Wojciech Trybus; Ewa Trybus; Teodora Król
Journal:  Int J Mol Sci       Date:  2022-07-31       Impact factor: 6.208
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.